Alaunos Therapeutics, Inc. (TCRT) Free cash flow 2016–2025
Alaunos Therapeutics, Inc. (TCRT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$3.0MFY2025 · since FY2016: -$58.9M → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | +40.3% |
| FY2024 | -$5.0M | +83.6% |
| FY2023 | -$30.3M | -3.0% |
| FY2022 | -$29.4M | +54.5% |
| FY2021 | -$64.8M | +3.0% |
| FY2020 | -$66.8M | -62.4% |
| FY2019 | -$41.1M | +17.6% |
| FY2018 | -$49.9M | +9.9% |
| FY2017 | -$55.4M | +5.9% |
| FY2016 | -$58.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice